Showing results (321-330 of 365) with videos related to

Sort By:
Pageof 37
Molecular Oncology|March 8, 2017
Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breastFelipe C Geyer, Kathleen A Burke, Salvatore Piscuoglio, et al.
The American Journal of Surgical Pathology|September 5, 2020
Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic DifferentiationPier Selenica, Niamh Conlon, Carlene Gonzalez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013A Oseledchyk, M M Leitao, J Konner, et al.
The American Journal of Surgical Pathology|March 20, 2018
NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of FibrosarcomaSarah Chiang, Paolo Cotzia, David M Hyman, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 8, 2020
Clinical patterns and genomic profiling of recurrent 'ultra-low risk' endometrial cancerMarina Stasenko, Noah Feit, Simon S K Lee, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 12, 2023
Proposal of Novel Binary Grading Systems for Cervical Squamous Cell CarcinomaSimona Stolnicu, Aaron M Praiss, Douglas Allison, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|October 28, 2022
Data Set for the Reporting of Endometrial Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR)Xavier Matias-Guiu, Christina I Selinger, Lyndal Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group StudyKristina W Thiel, Eric J Devor, Virginia L Filiaci, et al.
Pageof 37